Evaluation of the efficacy of rectal preparation from Hemoheal® Cream on number of excretion daily and rate of rectal bleeding in patients with Hemorrhoid

Vice Chancellor for Research, Kermanshah University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Patients who sign the testimonials and cooperate during the study
•Patients who their diseases are confirmed by complete medical evaluation including colonoscopy, pathology and laboratory data
•Only patients with mild to moderate hemorrhoids can be included in this study
•Patients who were not cured with Hemoheal cream during the last month

•4th-degree hemorrhoids
•Pregnant patients and nursing mothers
•Patients who have to use other drugs that interference with this medication
•Previous history of anorectal surgery
•Patients who are suffering from other diseases in addition to hemorrhoids, such as apparent coagulation abnormalities or kidney impairment accompanied with colorectal diseases such as cancer, Crohn's disease, ulcerative colitis, anal fistula, anal fissure, proctitis or perineal skin inflammation
•Patients who are disposed to a serious health danger, such as severe cardiac, liver or renal diseases
•If significant side effects occur, the patient will be excluded from the study and followed to end of the study
•Patients with severe allergy to this plant (dermatitis contact)

发起方

Vice Chancellor for Research, Kermanshah University of Medical Sciences